These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 27007612

  • 1. Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome.
    Saini I, Kalaivani M, Kabra SK.
    Rheumatol Int; 2016 Jul; 36(7):961-5. PubMed ID: 27007612
    [Abstract] [Full Text] [Related]

  • 2. Bisphosphonates in juvenile dermatomyositis with dystrophic calcinosis.
    Tayfur AC, Topaloglu R, Gulhan B, Bilginer Y.
    Mod Rheumatol; 2015 Jul; 25(4):615-20. PubMed ID: 25800510
    [Abstract] [Full Text] [Related]

  • 3. Juvenile dermatomyositis at a tertiary care hospital: is there any change in the last decade?
    Prasad S, Misra R, Agarwal V, Lawrence A, Aggarwal A.
    Int J Rheum Dis; 2013 Oct; 16(5):556-60. PubMed ID: 24164843
    [Abstract] [Full Text] [Related]

  • 4. Clinical features and disease course of patients with juvenile dermatomyositis.
    Gowdie PJ, Allen RC, Kornberg AJ, Akikusa JD.
    Int J Rheum Dis; 2013 Oct; 16(5):561-7. PubMed ID: 24164844
    [Abstract] [Full Text] [Related]

  • 5. Juvenile dermatomyositis: a tertiary center experience.
    Barut K, Aydin PO, Adrovic A, Sahin S, Kasapcopur O.
    Clin Rheumatol; 2017 Feb; 36(2):361-366. PubMed ID: 28058540
    [Abstract] [Full Text] [Related]

  • 6. Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children.
    Al-Mayouf SM, AlMutiari N, Muzaffer M, Shehata R, Al-Wahadneh A, Abdwani R, Al-Abrawi S, Abu-Shukair M, El-Habahbeh Z, Alsonbul A.
    Rheumatol Int; 2017 Sep; 37(9):1513-1517. PubMed ID: 28685324
    [Abstract] [Full Text] [Related]

  • 7. Early-onset juvenile dermatomyositis: A tertiary referral center experience and review of the literature.
    Sener S, Basaran O, Batu ED, Sag E, Oz S, Talim B, Bilginer Y, Haliloglu G, Ozen S.
    Semin Arthritis Rheum; 2023 Feb; 58():152133. PubMed ID: 36434896
    [Abstract] [Full Text] [Related]

  • 8. Long-term outcome in children with juvenile dermatomyositis: A single-center study from north India.
    Sharma A, Gupta A, Rawat A, Suri D, Singh S.
    Int J Rheum Dis; 2020 Mar; 23(3):392-396. PubMed ID: 31793219
    [Abstract] [Full Text] [Related]

  • 9. [Multi-center analysis of calcinosis in children with juvenile dermatomyositis].
    Miyamae T, Mori M, Inamo Y, Kohno Y, Takei S, Maeda M, Murata T, Nakata S, Kawai H, Hirano Y, Date Y, Kitamura K, Yokota S.
    Ryumachi; 2003 Jun; 43(3):538-43. PubMed ID: 12910962
    [Abstract] [Full Text] [Related]

  • 10. Characteristics and outcome of children with juvenile dermatomyositis in Cape Town: a cross-sectional study.
    Okong'o LO, Esser M, Wilmshurst J, Scott C.
    Pediatr Rheumatol Online J; 2016 Nov 11; 14(1):60. PubMed ID: 27835954
    [Abstract] [Full Text] [Related]

  • 11. Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional study.
    Faller G, Mistry BJ, Tikly M.
    Pediatr Rheumatol Online J; 2014 Jan 07; 12():2. PubMed ID: 24397895
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for developing calcinosis in juvenile dermatomyositis: subcutaneous and myofascial edema in initial magnetic resonance imaging.
    Yi BY, Marrs J, Acharya P, Sura A, Cidon M.
    Rheumatol Int; 2024 Nov 07; 44(11):2577-2582. PubMed ID: 37432516
    [Abstract] [Full Text] [Related]

  • 13. Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy.
    Ambler GR, Chaitow J, Rogers M, McDonald DW, Ouvrier RA.
    J Rheumatol; 2005 Sep 07; 32(9):1837-9. PubMed ID: 16142885
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis.
    Marco Puche A, Calvo Penades I, Lopez Montesinos B.
    Clin Exp Rheumatol; 2010 Sep 07; 28(1):135-40. PubMed ID: 20346254
    [Abstract] [Full Text] [Related]

  • 15. Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children.
    Pachman LM, Hayford JR, Chung A, Daugherty CA, Pallansch MA, Fink CW, Gewanter HL, Jerath R, Lang BA, Sinacore J, Szer IS, Dyer AR, Hochberg MC.
    J Rheumatol; 1998 Jun 07; 25(6):1198-204. PubMed ID: 9632086
    [Abstract] [Full Text] [Related]

  • 16. Age-dependent inhibition of ectopic calcification: a possible role for fetuin-A and osteopontin in patients with juvenile dermatomyositis with calcinosis.
    Marhaug G, Shah V, Shroff R, Varsani H, Wedderburn LR, Pilkington CA, Brogan PA.
    Rheumatology (Oxford); 2008 Jul 07; 47(7):1031-7. PubMed ID: 18448482
    [Abstract] [Full Text] [Related]

  • 17. Calcinosis in Juvenile Dermatomyositis-Epidemiology, Pathogenesis, Clinical Features, and Treatment: A Systematic Review.
    Gonçalves Júnior J, Shinjo SK.
    Curr Rheumatol Rep; 2024 Feb 07; 26(2):53-68. PubMed ID: 38060107
    [Abstract] [Full Text] [Related]

  • 18. [Analysis of the clinical characteristics and therapeutic effect of refractory juvenile dermatomyositis to tofacitinib].
    Zhou QF, Luo Y, He TY, Ling JY, Xu YB, Yang J, Xia Y.
    Zhonghua Er Ke Za Zhi; 2023 Jun 02; 61(6):538-542. PubMed ID: 37312466
    [Abstract] [Full Text] [Related]

  • 19. [A case of juvenile dermatomyositis with calcinosis universalis--remarkable improvement with aluminum hydroxide therapy].
    Aihara Y, Mori M, Ibe M, Kuriyama T, Takahashi Y, Shimizu C, Shike H, Mitsuda T, Yokota S.
    Ryumachi; 1994 Oct 02; 34(5):879-84. PubMed ID: 7801200
    [Abstract] [Full Text] [Related]

  • 20. Risk factors associated with calcinosis of juvenile dermatomyositis.
    Sallum AM, Pivato FC, Doria-Filho U, Aikawa NE, Liphaus BL, Marie SK, Silva CA.
    J Pediatr (Rio J); 2008 Oct 02; 84(1):68-74. PubMed ID: 18185899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.